HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Beautymerchant.com

This article was originally published in The Rose Sheet

Executive Summary

Standard Capital S.A., a Palm Beach, Fla. international investment banking firm, to assist beauty and personal care products e-tailer in raising capital and making strategic acquisition decisions, Beautymerchant announces Nov. 15. Acquisition candidates may include beauty manufacturers, distributors or other sites. The firm, which went public in September, recently announced the opening of Beautyworks, a chain of personal care salons for women cross-promoted with beautymerchant.com. The company also will run pre-holiday promos on iVillage.com's shopping and beauty channels under a new sponsorship agreement

You may also be interested in...



Beautymerchant To Target Older, Rural, Ethnic Women Following Online Study

Beautymerchant.com will change its target demographic after completing a study Nov. 22 which revealed the most targeted beauty e-tail customer - urban women ages 24-40 - represent less than 40% of online buyers, the Fort Lauderdale, Fla. discount e-tailer said.

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS008668

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel